TABLE 1.
Patient characteristics
| Variable | Group | All (n = 1124) |
Treatment group |
p value | ||
|---|---|---|---|---|---|---|
| SP alone (n = 331) |
Metastasectomy (n = 186) |
Non-surgical adjuvant therapies (n = 331) |
||||
| Age, years | ≤ 55 | 567 (50.4) | 102 (30.8) | 124 (66.7) | 341 (56.2) | < 0.001 |
| > 55 | 557 (49.6) | 229 (69.2) | 62 (33.3) | 266 (43.8) | ||
| Year of diagnosis | 2004–2006 | 275 (24.5) | 100 (30.2) | 35 (18.8) | 140 (23.1) | 0.024 |
| 2007–2009 | 347 (30.9) | 102 (30.8) | 62 (33.3) | 183 (30.2) | ||
| 2010–2013 | 502 (44.7) | 129 (39.0) | 89 (47.9) | 284 (46.8) | ||
| Sex | Male | 653 (58.1) | 185 (55.9) | 107 (57.5) | 361 (59.5) | 0.560 |
| Female | 471 (41.9) | 146 (44.1) | 79 (42.5) | 246 (40.5) | ||
| Race | White | 896 (79.7) | 259 (78.3) | 153 (82.3) | 484 (79.7) | 0.790 |
| Black | 162 (14.4) | 53 (16.0) | 22 (11.8) | 87 (14.3) | ||
| Other | 66 (5.9) | 19 (5.7) | 11 (5.9) | 36 (5.9) | ||
| Charleson–Deyo score | 0 | 908 (80.8) | 242 (73.1) | 153 (82.3) | 513 (84.5) | < 0.001 |
| 1+ | 216 (19.2) | 89 (26.9) | 33 (17.7) | 94 (15.5) | ||
| Facility location | Northeast | 163 (18.8) | 57 (19.3) | 28 (21.9) | 79 (17.6) | 0.537 |
| South | 309 (35.4) | 98 (33.2) | 41 (32.0) | 170 (37.8) | ||
| Midwest | 237 (27.1) | 87 (29.5) | 38 (29.7) | 112 (24.9) | ||
| West | 163 (18.8) | 53 (18.0) | 21 (16.4) | 89 (19.8) | ||
| Missing | 251 | |||||
| Facility type | Community or Network Cancer Program | 161 (18.4) | 60 (20.3) | 27 (21.1) | 74 (16.4) | 0.417 |
| Comprehensive Community Cancer Program | 206 (23.6) | 66 (22.4) | 25 (19.5) | 115 (25.6) | ||
| Academic or Research Program | 506 (58.0) | 169 (57.3) | 76 (59.4) | 261 (58.0) | ||
Bold values indicate statistical significance (p<0.05)
Data are expressed as n (%)
SP Surgical management of the primary site